Conroy Kevin T's Form 4 filing
Abbott Laboratories (ABT) · filed Sep 25, 2026
- Accession no.
- 0001306119-26-000009
- Filed
- Sep 25, 2026, 5:21 PM ET
- Trade date
- Sep 23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Conroy Kevin TCIK 0001306119 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Common shares without par value | FTax withholdingDisposed | −52,507 | $103.99 | −$5,460,202.93 | 81,230 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.